Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Mad Money Recap With Jim Cramer: Interest Rates Are the Key
By Scott Rutt
13 hours ago
INVESTING
GlaxoSmithKline and Sanofi Re-Start COVID Vaccine Trials
By Martin Baccardax
Feb 22, 2021 6:52 AM EST
INVESTING
Vir Biotech Jumps on New Drug Development Deal With GSK
By Dan Weil
Feb 17, 2021 10:20 AM EST
PRESS RELEASES
TUMS Expands Portfolio To Meet Consumer Demands For Naturally-Sourced Products
By PR Newswire
Feb 16, 2021 10:01 AM EST
INVESTING
UnitedHealth Retiring CEO to Get 2 Years of Salary, Bonus
By Rob Lenihan
Feb 9, 2021 1:47 PM EST
INVESTING
UnitedHealth Elevates President Andrew Witty to CEO
By Dan Weil
Feb 4, 2021 2:13 PM EST
INVESTING
CureVac Shares Leap On COVID Vaccine Pact With GlaxoSmithKline
By Martin Baccardax
Feb 3, 2021 10:03 AM EST
PRESS RELEASES
TUMS® Kicks Off $55,000 #TUMSBingoSweepstakes For The BIG GAME
By PR Newswire
Feb 1, 2021 10:00 AM EST
INVESTING
Pfizer and BioNTech Get Help From Sanofi on Vaccine Production
By M. Corey Goldman
Jan 27, 2021 6:35 AM EST
PRESS RELEASES
Moderna Provides Business Update And Announces Three New Development Programs In Infectious Disease Vaccines
By Business Wire
Jan 11, 2021 7:20 AM EST
PRESS RELEASES
Eligo Inks Deal With GSK Potentially Worth Up To $224M
By PR Newswire
Jan 11, 2021 7:00 AM EST
INVESTING
Eidos Reportedly Received $4.6 Billion Takeover Bid From Glaxo
By Dan Weil
Dec 14, 2020 9:10 AM EST
INVESTING
Morning Bell With Jim Cramer: Buy General Electric
By Fatma Khaled
Nov 23, 2020 8:40 AM EST
INVESTING
GlaxoSmithKline Joins COVID Vaccine Race With Phase 3 Trial
By Martin Baccardax
Nov 12, 2020 9:37 AM EST
INVESTING
Novavax Shares Off as Results Miss Estimates; New CFO Named
By Rob Lenihan
Nov 10, 2020 10:30 AM EST
Video
Diversification Key In Investing in Vaccine Race: Expert
Nov 2, 2020 10:35 AM EST
PRESS RELEASES
Robitussin Launches Their First-Ever Drug-Free Products For Cough Relief With A Cheerful Collaboration
By PR Newswire
Oct 28, 2020 8:48 AM EDT
INVESTING
Dunkin', Canon: 5 Top Stock Gainers for Monday
By Rob Lenihan
Oct 26, 2020 1:22 PM EDT
Video
Is PPE an Investing Opportunity Amid Race to Vaccine?
Oct 26, 2020 7:14 AM EDT
INVESTING
Vir, GlaxoSmithKline Widen Trials of Covid Treatment Candidate
By Tony Owusu
Oct 6, 2020 12:41 PM EDT
STOCKS
Nvidia Partners With GlaxoSmithKline to Use AI for Drug Development
By Rob Lenihan
Oct 5, 2020 11:22 AM EDT
PRESS RELEASES
ViiV Healthcare Presents A New Podcast About The Power Of Being Seen
By PR Newswire
Oct 1, 2020 9:05 AM EDT
PRESS RELEASES
FDA Approves Nucala As The First And Only Biologic Treatment For Hypereosinophilic Syndrome (HES)
By Business Wire
Sep 25, 2020 3:58 PM EDT
PRESS RELEASES
ViiV Healthcare Announces Availability Of CABENUVA And VOCABRIA In Canada
By PR Newswire
Sep 23, 2020 8:00 AM EDT
PRESS RELEASES
FDA Approves Trelegy Ellipta As The First Once-Daily Single Inhaler Triple Therapy For The Treatment Of Both Asthma And COPD In The US
By Business Wire
Sep 9, 2020 6:45 PM EDT
